Becker's ASC

Author's posts

10 signs that an employee is about to quit + 4 ways to make them stay

With the U.S. workforce in the midst of the “great resignation,” it is critical that employers are aware of the warning signs that they could be losing an employee. 

Dr. Leon Rafailov now among Long Island’s first surgeons to perform corneal neurotization

Leon Rafailov, MD, an oculoplastic surgeon at SightMD who specializes in minimally invasive procedures, has become one of the first physicians in Long Island (N.Y.) to perform a corneal neurotization. 

23 gastrointestinal drugs facing shortages

The drug market is not impervious to worldwide supply chain issues, and gastroenterologists are experiencing drug shortages like most other physicians this year. 

9 ophthalmology drugs in short supply

The drug market is not impervious to worldwide supply chain issues, and ophthalmologists are experiencing drug shortages like most other physicians this year. 

$134.8M paid for California medical office building portfolio

A four-building medical office portfolio has been bought for $134.8 million, Commercial Property Executive reported Aug. 24.

Blood supply shortages, a defibrillator recall and 6 more supply chain updates

Here are supply chain updates that have been reported by Becker’s since Aug. 16:

Prism Vision Group acquires 8-physician practice with ASC

New Providence, N.J.-based Prism Vision Group, a vertically integrated eye care services organization, has added Seidenberg Protzko Eye Associates to its platform.

Former Optum exec named CEO of tech-based healthcare company

MOBE, a healthcare company that uses data to better treat its customers and lower health system costs, named former Optum executive Mike Ott as CEO Aug. 23. 

Administrator of the week: Jeffery Flynn, an ASC exec with 20+ years of experience

Jeffrey Flynn, administrator and COO of New York City-based Gramercy Surgery Center, is Becker’s inaugural administrator of the week.

What 3 ASC leaders see as key investments

From staffing to technology, here is where three ASC leaders and surgeons are directing their investments: